Study S002000

A Multi-centre, Prospective, Non-interventional Study Investigating the Effect of Victoza® in Patients With Type 2 Diabetes in Iran Followed in a Real World Setting

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT03888157
Acronym: VIEW-Iran
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 839
Start: 2019-03-10
Primary completion: 2020-10-21
Lead sponsor: Novo Nordisk A/S
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG:Liraglutide
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: OTHER:U1111-1213-4238

Registered primary outcomes

Change in glycated haemoglobin A1c (HbA1c) (percentage) [Week 0, week 26]
Change in HbA1c (mmol/mol) [Week 0, week 26]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.